White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.


Journal

Cancer metastasis reviews
ISSN: 1573-7233
Titre abrégé: Cancer Metastasis Rev
Pays: Netherlands
ID NLM: 8605731

Informations de publication

Date de publication:
09 2022
Historique:
received: 01 07 2022
accepted: 27 07 2022
pubmed: 5 8 2022
medline: 16 9 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

Obesity represents an important risk factor for prostate cancer, driving more aggressive disease, chemoresistance, and increased mortality. White adipose tissue (WAT) overgrowth in obesity is central to the mechanisms that lead to these clinical observations. Adipose stromal cells (ASCs), the progenitors to mature adipocytes and other cell types in WAT, play a vital role in driving PCa aggressiveness. ASCs produce numerous factors, especially chemokines, including the chemokine CXCL12, which is involved in driving EMT and chemoresistance in PCa. A greater understanding of the impact of WAT in obesity-induced progression of PCa and the underlying mechanisms has begun to provide opportunities for developing interventional strategies for preventing or offsetting these critical events. These include weight loss regimens, therapeutic targeting of ASCs, use of calorie restriction mimetic compounds, and combinations of compounds as well as specific receptor targeting strategies.

Identifiants

pubmed: 35927363
doi: 10.1007/s10555-022-10056-0
pii: 10.1007/s10555-022-10056-0
pmc: PMC9474694
mid: NIHMS1828762
doi:

Substances chimiques

Chemokine CXCL12 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

649-671

Subventions

Organisme : NCI NIH HHS
ID : R01 CA196259
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA228404
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Cancer Invest. 1993;11(6):743-50
pubmed: 8221207
Cancer Res. 2013 Sep 15;73(18):5633-46
pubmed: 23878190
J Exp Med. 1996 Sep 1;184(3):1101-9
pubmed: 9064327
Neoplasia. 2007 Jul;9(7):556-62
pubmed: 17710158
Breast Cancer Res. 2016 May 28;18(1):57
pubmed: 27233359
Front Immunol. 2019 Jan 08;9:3063
pubmed: 30671055
Epidemiol Rev. 2001;23(1):126-31
pubmed: 11588836
Front Endocrinol (Lausanne). 2016 Jul 14;7:90
pubmed: 27471491
Neoplasia. 2008 Mar;10(3):244-54
pubmed: 18320069
Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):258-264
pubmed: 30464020
Int J Cancer. 2016 Feb 15;138(4):866-74
pubmed: 26356247
Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
Oncotarget. 2016 Dec 13;7(50):83829-83830
pubmed: 28082729
Cancer Discov. 2012 Apr;2(4):328-43
pubmed: 22576210
Front Oncol. 2021 Feb 25;11:569295
pubmed: 33747905
Annu Rev Med. 2010;61:301-16
pubmed: 19824817
Clin Cancer Res. 2011 Apr 15;17(8):2074-80
pubmed: 21349998
Am J Pathol. 2006 Nov;169(5):1505-22
pubmed: 17071576
Int J Oncol. 2006 Mar;28(3):737-45
pubmed: 16465380
Oncol Rep. 2014 May;31(5):2049-54
pubmed: 24604010
Int J Environ Res Public Health. 2022 Jan 15;19(2):
pubmed: 35055794
Cancer Lett. 2019 Jul 10;454:1-13
pubmed: 30974114
Biomedicines. 2018 Sep 09;6(3):
pubmed: 30205595
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
Nat Med. 2016 Oct;22(10):1120-1130
pubmed: 27571348
Science. 1993 Jul 2;261(5117):101-3
pubmed: 8316840
Nat Commun. 2013;4:2192
pubmed: 23900241
Mol Carcinog. 2018 Mar;57(3):393-407
pubmed: 29197120
Obesity (Silver Spring). 2011 Aug;19(8):1722-6
pubmed: 21293449
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):8649-8654
pubmed: 28739898
Nat Commun. 2016 Jan 12;7:10230
pubmed: 26756352
Neoplasia. 2015 Dec;17(12):849-861
pubmed: 26696367
Cell. 2006 Dec 15;127(6):1109-22
pubmed: 17112576
Cells. 2018 Aug 17;7(8):
pubmed: 30126117
Cancer Res Treat. 2015 Apr;47(2):306-12
pubmed: 25483747
Basic Res Cardiol. 2010 Sep;105(5):665-76
pubmed: 20508941
Cancer Prev Res (Phila). 2012 Oct;5(10):1236-46
pubmed: 22896210
Cell Stem Cell. 2016 Jul 7;19(1):23-37
pubmed: 27374788
Oncotarget. 2013 Nov;4(11):2108-23
pubmed: 24240026
J Leukoc Biol. 1995 Jan;57(1):180-7
pubmed: 7829970
Br J Nutr. 2013 Oct;110(8):1534-47
pubmed: 23591120
PLoS One. 2012;7(2):e30563
pubmed: 22363446
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):57-64
pubmed: 25527697
Biochem Biophys Res Commun. 2004 Jul 30;320(3):656-63
pubmed: 15240098
Oncotarget. 2017 Mar 14;8(11):18280-18295
pubmed: 28407685
Am J Clin Nutr. 2017 Jul;106(1):113-124
pubmed: 28515070
JBI Database System Rev Implement Rep. 2018 Feb;16(2):507-547
pubmed: 29419624
BMC Med. 2012 Sep 25;10:108
pubmed: 23009291
Urology. 2012 Sep;80(3):576-84
pubmed: 22925233
Rev Urol. 2004 Spring;6(2):73-81
pubmed: 16985580
J Surg Res. 2011 Nov;171(1):143-50
pubmed: 20462600
Stem Cell Res. 2012 Mar;8(2):312-23
pubmed: 22209011
Cell Cycle. 2008 Sep 1;7(17):2769-73
pubmed: 18728386
J Clin Endocrinol Metab. 2002 Oct;87(10):4602-6
pubmed: 12364441
Nature. 2009 Jul 16;460(7253):392-5
pubmed: 19587680
Turk J Gastroenterol. 2019 Dec;30(12):1030-1035
pubmed: 31854308
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2738-2749
pubmed: 32196625
Cancer Metab. 2017 Jan 13;5:1
pubmed: 28101337
Oncotarget. 2015 Mar 10;6(7):5022-40
pubmed: 25669980
JCI Insight. 2017 Feb 23;2(4):e87489
pubmed: 28239646
Cancer Prev Res (Phila). 2015 Jul;8(7):597-606
pubmed: 25908508
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14776-81
pubmed: 25267627
Urol Oncol. 2013 Oct;31(7):997-1002
pubmed: 21925906
Endocrinology. 2008 Jul;149(7):3549-58
pubmed: 18403477
Cancer Res. 2016 Jan 15;76(2):491-504
pubmed: 26744520
Nat Rev Cancer. 2008 Mar;8(3):205-11
pubmed: 18235448
Cell Prolif. 2011 Aug;44(4):311-9
pubmed: 21645150
Nutr Metab (Lond). 2012 Jun 29;9(1):64
pubmed: 22748184
Brain Behav Immun. 2014 May;38:38-52
pubmed: 24263070
Arch Physiol Biochem. 2008 Feb;114(1):23-37
pubmed: 18465356
Obes Rev. 2011 Jul;12(7):e593-601
pubmed: 21410865
Mol Cancer. 2013 Jul 31;12(1):85
pubmed: 23902739
PLoS One. 2013 Jun 18;8(6):e66515
pubmed: 23824685
Food Funct. 2014 Jun;5(6):1241-9
pubmed: 24722352
Anticancer Res. 2003 Jan-Feb;23(1A):363-98
pubmed: 12680238
J Appl Physiol (1985). 2005 Dec;99(6):2128-36
pubmed: 16051710
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Mol Metab. 2015 Aug 12;4(11):779-94
pubmed: 26629403
Front Endocrinol (Lausanne). 2012 Jan 03;2:102
pubmed: 22654837
Metabolism. 2008 Jul;57(7 Suppl 1):S39-46
pubmed: 18555853
Curr Med Chem. 2013;20(33):4185-4194
pubmed: 23992306
Trends Cancer. 2018 May;4(5):374-384
pubmed: 29709261
Cancer Prev Res (Phila). 2014 Jan;7(1):54-64
pubmed: 24196830
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Prostate. 2007 Nov 1;67(15):1641-53
pubmed: 17823925
J Cell Sci. 2012 Nov 15;125(Pt 22):5467-78
pubmed: 22956548
J Clin Oncol. 2020 Jun 20;38(18):2018-2027
pubmed: 32250715
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6889-94
pubmed: 16203779
Cancer Prev Res (Phila). 2011 Dec;4(12):2002-14
pubmed: 21952584
Nat Commun. 2016 May 31;7:11674
pubmed: 27241286
J Clin Invest. 2003 Dec;112(12):1821-30
pubmed: 14679177
Cell Metab. 2009 Apr;9(4):339-49
pubmed: 19356715
J Biol Chem. 2012 Feb 17;287(8):5744-55
pubmed: 22203670
JCI Insight. 2021 Sep 8;6(17):
pubmed: 34314388
Chem Biol. 2011 Jul 29;18(7):846-56
pubmed: 21802006
BMJ Open. 2018 May 14;8(5):e022899
pubmed: 29764892
J Lipid Res. 2014 Mar;55(3):363-74
pubmed: 24465016
Cell Metab. 2014 Aug 5;20(2):368-375
pubmed: 24998914
Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2150-4
pubmed: 17932364
Trends Endocrinol Metab. 2014 May;25(5):255-62
pubmed: 24731595
Cancer Metastasis Rev. 2010 Dec;29(4):641-53
pubmed: 20821253
Nutr Metab (Lond). 2011 May 10;8(1):29
pubmed: 21569266
Am J Clin Nutr. 2016 Jul;104(1):215-27
pubmed: 27194304
PLoS One. 2012;7(1):e28784
pubmed: 22253696
Pathology. 2006 Aug;38(4):309-11
pubmed: 16916718
Mol Cancer. 2010 Apr 22;9:85
pubmed: 20412587
Clin Cancer Res. 2012 Feb 1;18(3):771-82
pubmed: 22167410
J Biol Chem. 2011 Sep 16;286(37):32188-97
pubmed: 21730065
Cell Death Dis. 2017 Feb 2;8(2):e2593
pubmed: 28151470
Cancer Lett. 2011 Dec 15;312(1):62-72
pubmed: 21890265
FASEB J. 2009 Mar;23(3):823-34
pubmed: 19001056
Surg Oncol. 2020 Dec;35:182-188
pubmed: 32889251
Nutr Rev. 2021 Jan 1;79(1):98-113
pubmed: 32940695
Cell. 1998 Mar 20;92(6):829-39
pubmed: 9529258
Cancer Res. 2012 Oct 15;72(20):5198-208
pubmed: 23071132
J Clin Endocrinol Metab. 2021 Jan 1;106(1):64-79
pubmed: 33017844
Prostate. 2012 Dec 1;72(16):1779-88
pubmed: 22514016
Neuro Oncol. 2005 Apr;7(2):122-33
pubmed: 15831231
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3052-7
pubmed: 9096344
J Urol. 2004 Sep;172(3):910-4
pubmed: 15310996
Urol Oncol. 2021 Aug;39(8):495.e7-495.e15
pubmed: 33563536
J Clin Oncol. 2011 Feb 20;29(6):726-32
pubmed: 21205749
Cancer Prev Res (Phila). 2017 Apr;10(4):235-243
pubmed: 28270386
J Exp Med. 1992 Jul 1;176(1):59-65
pubmed: 1613466
J Transl Med. 2021 Apr 17;19(1):156
pubmed: 33865426
NPJ Precis Oncol. 2021 Mar 22;5(1):26
pubmed: 33753872
Adipocyte. 2016 Aug 12;5(4):369-374
pubmed: 27994950
Prostate. 2005 Mar 1;62(4):316-21
pubmed: 15389806
Cell Death Differ. 2015 Feb;22(2):351-63
pubmed: 25342467
PLoS One. 2012;7(7):e38375
pubmed: 22848341
Nat Rev Endocrinol. 2014 Aug;10(8):455-465
pubmed: 24935119
Cancer Sci. 2008 Mar;99(3):539-42
pubmed: 18201276
Nature. 2017 Jun 7;546(7657):234-242
pubmed: 28593971
Eur J Cancer. 2013 Jan;49(1):219-30
pubmed: 22683307
Korean J Urol. 2011 Sep;52(9):607-11
pubmed: 22025955
Genes Nutr. 2014 Sep;9(5):418
pubmed: 25047408
Cell Death Dis. 2020 Apr 16;11(4):234
pubmed: 32300100
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373107
Int J Obes (Lond). 2005 Jan;29(1):146-50
pubmed: 15520826
PLoS One. 2014 Feb 28;9(2):e89595
pubmed: 24586900
Cancer Res. 2015 Jan 15;75(2):456-71
pubmed: 25425006
J Leukoc Biol. 2005 Feb;77(2):257-66
pubmed: 15561756
Cancer Causes Control. 2014 Aug;25(8):933-43
pubmed: 24810654
Mol Cancer Ther. 2011 Mar;10(3):427-36
pubmed: 21282354
Biochem Biophys Res Commun. 1995 Dec 26;217(3):1255-62
pubmed: 8554584
J Appl Physiol (1985). 2017 Mar 1;122(3):675-682
pubmed: 28082336
PLoS One. 2013 Dec 02;8(12):e81859
pubmed: 24312594
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20611-6
pubmed: 24218555
Breast Cancer Res. 2011;13(6):R128
pubmed: 22152016
Theranostics. 2013;3(1):26-33
pubmed: 23382783
J Urol. 2009 Oct;182(4):1621-7
pubmed: 19683746
Mol Carcinog. 2010 Nov;49(11):923-7
pubmed: 20842668
Cancer Res. 2013 Oct 1;73(19):5880-91
pubmed: 23918796
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):469-73
pubmed: 26466066
Br J Cancer. 2012 Jun 5;106(12):1901-6
pubmed: 22596239
Cell Physiol Biochem. 2012;29(1-2):233-40
pubmed: 22415092
Cell Commun Signal. 2016 Oct 27;14(1):26
pubmed: 27784296
Free Radic Biol Med. 2007 Mar 1;42(5):665-74
pubmed: 17291990
Mech Ageing Dev. 2012 May;133(5):255-66
pubmed: 22414572
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e374-81
pubmed: 25091359
Nutrients. 2022 May 23;14(10):
pubmed: 35631305
PLoS One. 2012;7(12):e51655
pubmed: 23272133
Cancer Metastasis Rev. 2010 Dec;29(4):709-22
pubmed: 20839032
Nutr Res Pract. 2016 Apr;10(2):175-81
pubmed: 27087901
Sci Rep. 2017 Dec 19;7(1):17880
pubmed: 29259281
Cancer Res. 2011 Apr 1;71(7):2455-65
pubmed: 21459803
Blood. 2009 Jun 11;113(24):6085-93
pubmed: 19380869
Eur Urol. 2010 Feb;57(2):179-92
pubmed: 19931974
Front Public Health. 2017 Feb 14;5:19
pubmed: 28261579
Nat Rev Urol. 2021 Sep;18(9):519-542
pubmed: 34158658
J Bone Miner Res. 2010 Sep;25(9):2078-88
pubmed: 20229598
Cancer. 2012 May 1;118(9):2338-66
pubmed: 22460733
Nat Rev Immunol. 2011 Feb;11(2):85-97
pubmed: 21252989
Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2461-8
pubmed: 21930958
NPJ Precis Oncol. 2017;1:
pubmed: 29202102
Int J Mol Sci. 2021 Apr 25;22(9):
pubmed: 33922898
Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):146-153
pubmed: 29141853
Cancer Prev Res (Phila). 2017 Sep;10(9):494-506
pubmed: 28864539
Br J Nutr. 2004 Sep;92(3):347-55
pubmed: 15469638
Int J Oncol. 2018 Jul;53(1):358-370
pubmed: 29749439
JAMA. 1999 May 5;281(17):1591-7
pubmed: 10235151
Int J Mol Sci. 2013 Jul 03;14(7):13782-95
pubmed: 23823800
Eur Heart J. 2010 Aug;31(15):1924-34
pubmed: 20299351
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78
pubmed: 19755644
Cancer Res. 2017 Sep 15;77(18):5158-5168
pubmed: 28687617
Free Radic Biol Med. 2017 Feb;103:165-176
pubmed: 27979659
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Front Immunol. 2014 Sep 15;5:440
pubmed: 25309539
Clin Exp Metastasis. 2015 Apr;32(4):353-68
pubmed: 25802102
Nutr Res. 2014 Oct;34(10):837-43
pubmed: 25311610
Clin Cancer Res. 2010 Jun 1;16(11):2927-31
pubmed: 20484021
Obesity (Silver Spring). 2008 Sep;16(9):2081-7
pubmed: 18551111
Prostate Cancer Prostatic Dis. 2022 Mar;25(1):86-92
pubmed: 35152272
Eur Urol. 2013 May;63(5):800-9
pubmed: 23219374
Crit Rev Food Sci Nutr. 2021;61(8):1293-1304
pubmed: 32363896
Cancer. 2016 Mar 1;122(5):722-9
pubmed: 26619367
PeerJ. 2018 Jun 14;6:e4928
pubmed: 29915688
Mol Cell Endocrinol. 2001 Apr 25;175(1-2):81-92
pubmed: 11325518
Cancer Prev Res (Phila). 2011 Apr;4(4):544-51
pubmed: 21325564
J Cell Biochem. 2003 Jun 1;89(3):462-73
pubmed: 12761880
Oncogene. 2022 Sep 10;:
pubmed: 36088505
Metab Syndr Relat Disord. 2014 Dec;12(10):497-501
pubmed: 25137036
Endocr Relat Cancer. 2015 Dec;22(6):R365-86
pubmed: 26373570
Aging (Albany NY). 2012 May;4(5):320-9
pubmed: 22589237
Clin Cancer Res. 2015 Oct 1;21(19):4278-85
pubmed: 26199389
Mol Cancer. 2013 Jun 18;12:64
pubmed: 23773523
Brain Behav Immun. 2019 Oct;81:92-104
pubmed: 31454519
J Clin Invest. 2006 Jun;116(6):1494-505
pubmed: 16691291
Exp Biol Med (Maywood). 2012 Oct;237(10):1155-62
pubmed: 23038706
Biochem J. 2019 Nov 29;476(22):3533-3548
pubmed: 31710352
Int J Mol Sci. 2021 May 24;22(11):
pubmed: 34074045
J Nutr. 2009 May;139(5):919-25
pubmed: 19297423
Cell Biosci. 2020 Mar 10;10:32
pubmed: 32175075
Oncogene. 2019 Mar;38(11):1979-1988
pubmed: 30361686
J Bone Miner Res. 2021 Jun;36(6):1145-1158
pubmed: 33651379
Aging Cell. 2007 Oct;6(5):673-88
pubmed: 17874999
J Pathol. 2011 Jan;223(2):283-94
pubmed: 21125681
Cancer Prev Res (Phila). 2011 Apr;4(4):486-501
pubmed: 21233290
Front Physiol. 2021 Dec 09;12:780666
pubmed: 34955891
J Exp Clin Cancer Res. 2012 Apr 02;31:32
pubmed: 22469146
Nutr Cancer. 2021;73(11-12):2671-2686
pubmed: 33295204
Endocr Rev. 2011 Aug;32(4):550-70
pubmed: 21642230
J Immunol. 2009 Sep 1;183(5):2895-7
pubmed: 19696428
Cancer Prev Res (Phila). 2011 Jul;4(7):1011-20
pubmed: 21733825
Front Immunol. 2019 Dec 13;10:2759
pubmed: 31921102
Breast. 2011 Oct;20 Suppl 3:S31-5
pubmed: 22015290
Br J Nutr. 2012 Dec 28;108(12):2166-75
pubmed: 22414733
Nat Rev Cancer. 2011 Nov 24;11(12):886-95
pubmed: 22113164
Prostate Cancer Prostatic Dis. 2018 Jun;21(2):212-220
pubmed: 29203893
Prostate. 2020 Sep;80(12):977-985
pubmed: 32542727
Clin Cancer Res. 2008 Nov 1;14(21):6735-41
pubmed: 18980965
Mol Ther. 2016 Feb;24(1):34-40
pubmed: 26316391
J Clin Endocrinol Metab. 2009 Jun;94(6):2129-36
pubmed: 19318450
BJU Int. 2011 Jun;107(11):1775-9
pubmed: 21050356
J Clin Endocrinol Metab. 2007 Sep;92(9):3646-52
pubmed: 17566089
J Natl Cancer Inst. 1993 Oct 6;85(19):1571-9
pubmed: 8105097
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Plast Reconstr Surg. 2015 Feb;135(2):340e-350e
pubmed: 25626819
J Urol. 2004 Aug;172(2):520-4
pubmed: 15247719
Nat Commun. 2013;4:1795
pubmed: 23653207
FASEB J. 2004 Aug;18(11):1240-2
pubmed: 15180966
Breast Cancer Res. 2015 Apr 24;17:57
pubmed: 25908175
Prog Lipid Res. 2013 Oct;52(4):585-9
pubmed: 24001676
Int J Cancer. 2000 May 20;89(3):259-64
pubmed: 10861502
J Physiol. 2018 Jul;596(14):2811-2822
pubmed: 29923191
Nutr Metab Cardiovasc Dis. 2013 May;23(5):403-9
pubmed: 22118955
J Bone Miner Res. 2005 Feb;20(2):318-29
pubmed: 15647826
Biochim Biophys Acta. 2013 Oct;1831(10):1518-32
pubmed: 23562839
Neoplasia. 2001 Jan-Feb;3(1):33-42
pubmed: 11326314
BJU Int. 2018 May;121 Suppl 3:9-21
pubmed: 29460324
J Exp Med. 1997 Jan 6;185(1):111-20
pubmed: 8996247
Am J Clin Pathol. 2008 Sep;130(3):382-8
pubmed: 18701411
Carcinogenesis. 2007 Sep;28(9):1946-53
pubmed: 17675339
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H392-H402
pubmed: 29167123
Immunol Rev. 2012 Sep;249(1):218-38
pubmed: 22889225
Br J Cancer. 2017 Oct 24;117(9):1303-1313
pubmed: 28881355
Aging Cell. 2017 Jun;16(3):497-507
pubmed: 28156058
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
Exp Gerontol. 2019 Apr;118:55-64
pubmed: 30620889
Int J Obes (Lond). 2011 May;35(5):714-27
pubmed: 20921964
J Biol Chem. 2008 Feb 15;283(7):4283-94
pubmed: 18057003
Cancer Metab. 2013 Mar 07;1(1):10
pubmed: 24280167
J Cell Biol. 2012 Feb 20;196(4):395-406
pubmed: 22351925
Clin Genitourin Cancer. 2014 Feb;12(1):21-6
pubmed: 24269373
J Acad Nutr Diet. 2018 Apr;118(4):714-723.e1
pubmed: 27988219
Anat Rec. 2000 Oct 1;260(2):141-7
pubmed: 10993951
Science. 2005 Oct 14;310(5746):314-7
pubmed: 16224023
Cancer Res. 2012 Jan 1;72(1):325-34
pubmed: 22052460
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176
Gastroenterology. 2007 May;132(6):2208-25
pubmed: 17498513
Exp Gerontol. 2010 Oct;45(10):763-71
pubmed: 20619334
Obesity (Silver Spring). 2016 Jul;24(7):1454-63
pubmed: 27221771
Cancer Res. 2011 Jun 1;71(11):3889-95
pubmed: 21610110
Prostate. 2008 Jan 1;68(1):11-9
pubmed: 17999389
Ann Plast Surg. 2015 Jun;74(6):728-36
pubmed: 24401810
J Pharmacol Sci. 2009 Apr;109(4):496-503
pubmed: 19372632
J Transl Med. 2018 Dec 24;16(1):371
pubmed: 30583725
Cell Metab. 2019 Apr 2;29(4):844-855.e3
pubmed: 30595477
Pathol Res Pract. 2014 Feb;210(2):74-8
pubmed: 24252309
Trends Endocrinol Metab. 2008 Jan;19(1):3-9
pubmed: 18155916
Drug Discov Today. 2013 Jun;18(11-12):567-73
pubmed: 22627005
Endocrinology. 2008 Mar;149(3):942-9
pubmed: 18202123
Mol Ther Oncolytics. 2017 May 17;6:1-9
pubmed: 28607949
Cell. 2014 Jan 16;156(1-2):20-44
pubmed: 24439368
Aging Cell. 2006 Apr;5(2):97-108
pubmed: 16626389
Adipocyte. 2014 Apr 1;3(2):97-106
pubmed: 24719782
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70
pubmed: 12756299
Prostate Cancer Prostatic Dis. 2011 Dec;14(4):361-6
pubmed: 21894174
Ann Anat. 2013 Mar;195(2):103-10
pubmed: 23279723
Pediatr Res. 2007 Apr;61(4):491-5
pubmed: 17515877
Cancer Res. 2009 Jun 15;69(12):5259-66
pubmed: 19491274

Auteurs

Achinto Saha (A)

Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78723, USA.
Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, TX, 78723, USA.
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA.

Jill Hamilton-Reeves (J)

Departments of Urology and Dietetics & Nutrition, University of Kansas Medical Center, Kansas City, KS, 66160, USA.

John DiGiovanni (J)

Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX, 78723, USA. john.digiovanni@austin.utexas.edu.
Center for Molecular Carcinogenesis and Toxicology, The University of Texas at Austin, Austin, TX, 78723, USA. john.digiovanni@austin.utexas.edu.
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX, 78723, USA. john.digiovanni@austin.utexas.edu.
Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, 1400 Barbara Jordan Blvd, Austin, TX, 78723, USA. john.digiovanni@austin.utexas.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH